ChiCTR2600123130 版本V1.0 版本创建时间2026/04/22 09:27:00 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600123130 

最近更新日期:

Date of Last Refreshed on:

2026-04-22 09:26:30 

注册时间:

Date of Registration:

2026-04-22 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

脑卒中后偏瘫患者膈肌功能障碍发生率及膈肌代偿收缩指数的研究

Public title:

Incidence and Diaphragmatic Compensatory Contraction Index of Diaphragmatic Dysfunction in Post-Stroke Hemiplegic Patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

脑卒中后偏瘫患者膈肌功能障碍发生率及膈肌代偿收缩指数的研究

Scientific title:

Incidence and Diaphragmatic Compensatory Contraction Index of Diaphragmatic Dysfunction in Post-Stroke Hemiplegic Patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

赵浩天 

研究负责人:

赵浩天 

Applicant:

Zhao Haotian 

Study leader:

Zhao Haotian 

申请注册联系人电话:

Applicant telephone:

+86 151 0018 5988

研究负责人电话:

Study leader's
telephone:

+86 151 0018 5988

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1011192637@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1011192637@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河北省石家庄市新华区和平西路348号

研究负责人通讯地址:

河北省石家庄市新华区和平西路348号

Applicant address:

No. 348, Heping West Road, Xinhua District, Shijiazhuang, Hebei

Study leader's address:

No. 348, Heping West Road, Xinhua District, Shijiazhuang, Hebei

申请注册联系人邮政编码:

Applicant postcode:

050051

研究负责人邮政编码:

Study leader's postcode:

050051

申请人所在单位:

河北省人民医院

Applicant's institution:

Hebei General Hospital

研究负责人所在单位:

河北省人民医院

Affiliation of the Leader:

Hebei General Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2026 科研伦审第(1)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

河北省人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Hebei General Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2026-01-04 00:00:00

伦理委员会联系人:

鲁杨

Contact Name of the ethic committee:

Lu Yang

伦理委员会联系地址:

河北省石家庄市新华区和平西路348号

Contact Address of the ethic committee:

No. 348, Heping West Road, Xinhua District, Shijiazhuang, Hebei

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 311 8598 8311

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

河北省人民医院

Primary sponsor:

Hebei General Hospital

研究实施负责(组长)单位地址:

河北省石家庄市新华区和平西路348号

Primary sponsor's address:

No. 348, Heping West Road, Xinhua District, Shijiazhuang, Hebei

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河北省

市(区县):

石家庄

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

河北省人民医院

具体地址:

河北省石家庄市新华区和平西路348号

Institution
hospital:

Hebei General Hospital

Address:

No. 348, Heping West Road, Xinhua District, Shijiazhuang, Hebei

经费或物资来源:

自筹

Source(s) of funding:

Self-financed

研究疾病:

脑卒中合并偏瘫  

Target disease:

Stroke combined with hemiplegia

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究是一项单中心、回顾性、观察性研究,探究脑卒中恢复期合并偏瘫患者的膈肌功能障碍的发生率,并计算膈肌代偿收缩指数。  

Objectives of Study:

This was a single-center, retrospective, observational study focused on determining the incidence of diaphragmatic dysfunction and calculating the diaphragmatic compensatory contraction index in patients with hemiplegia during the recovery phase of stroke.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合卒中诊断标准,确诊为脑梗死或脑出血; 2.年龄>=18岁,<= 99岁; 3.处于卒中后康复阶段(首次卒中事件1个月后),且合并一侧肢体偏瘫; 4.经肺CT、胸片或肺超声检查未发现明显异常肺部疾病; 5.具有完整的膈肌超声检查报告数据。

Inclusion criteria

1. Diagnosed with cerebral infarction or intracerebral hemorrhage according to standard stroke diagnostic criteria; 2. Age between 18 and 99 years (inclusive); 3. In the post-stroke rehabilitation phase (>=1 month after the first stroke event) and presenting with unilateral limb hemiplegia; 4. No significant pulmonary diseases as confirmed by lung CT, chest X-ray, or lung ultrasound; 5. Availability of complete diaphragm ultrasound examination report data.

排除标准:

1.患有心脏、脑部、肺脏等器官急性疾病; 2.胸部或腹部手术史或肿瘤; 3.存在已知的导致的膈肌功能障碍的其它因素; 4.超声图像质量差或数据不完整; 5.接受持续性有创机械通气治疗。

Exclusion criteria:

1. Presence of acute diseases affecting the heart, brain, or lungs; 2. History of thoracic or abdominal surgery, or thoracic/abdominal tumors; 3. Known factors other than stroke that could lead to diaphragmatic dysfunction; 4. Poor quality of ultrasound images or incomplete data; 5. Requirement for ongoing invasive mechanical ventilation.

研究实施时间:

Study execute time:

From 2025-04-01 00:00:00 To 2026-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-05-01 00:00:00 To 2026-08-31 00:00:00

干预措施:

Interventions:

组别:

脑卒中后偏瘫组

样本量:

297

Group:

Post stroke hemiplegic group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河北 

市(区县):

石家庄 

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

河北省人民医院 

单位级别:

三甲 

Institution
hospital:

Hebei General Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

膈肌功能障碍发生率

指标类型:

主要指标

Outcome:

Incidence of diaphragmatic dysfunction

Type:

Primary indicator

测量时间点:

超声测量时

测量方法:

使用超声测量膈肌厚度和收缩功能

Measure time point of outcome:

During ultrasonic measurement

Measure method:

Using ultrasound to measure diaphragm thickness and systolic function

指标中文名:

呼吸困难率

指标类型:

次要指标

Outcome:

Incidence of dyspnea

Type:

Secondary indicator

测量时间点:

病例入组时间

测量方法:

根据呼吸频率、氧饱和度、患者主观呼吸困难感受或是否接受呼吸支持治疗

Measure time point of outcome:

Case enrollment time

Measure method:

Based on respiratory rate, oxygen saturation, the patient's subjective feeling of dyspnea, or whether they receive respiratory support therapy

指标中文名:

膈肌代偿收缩指数

指标类型:

次要指标

Outcome:

Compensatory contraction index of diaphragm

Type:

Secondary indicator

测量时间点:

超声测量时

测量方法:

使用超声测量膈肌收缩功能并计算健侧与患侧比值

Measure time point of outcome:

During ultrasonic measurement

Measure method:

Use ultrasound to measure diaphragm contraction function and calculate the ratio of healthy side to affected side

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 99 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表(纸质版记录表和电子版Excel记录表)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Report Forms (paper-based records and electronic Excel spreadsheets)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-04-22 09:26:30